Xilio Therapeutics Cash Flow Statement (2020-2026) | XLO

Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-23.01M-16.25M-19.70M-21.35M-24.55M-20.21M-23.17M-23.53M-20.12M-17.36M-18.13M-17.49M-14.70M-14.76M-13.63M-13.85M-14.37M-1.93M-11.84M-14.11M
Depreciation and Depletion (Quarter)
0.30M0.30M0.40M0.40M0.40M0.50M0.40M0.50M0.40M0.50M0.40M0.40M0.40M0.40M0.40M0.50M0.40M0.30M0.30M0.30M
Share-based Compensation (Quarter)
1.00M1.09M2.07M2.03M2.71M1.87M1.81M1.79M1.80M1.86M1.93M1.83M1.51M1.57M1.52M1.53M1.35M1.12M2.93M2.21M
Gains from Sales and Divestitures (Quarter)
0.08M0.10M0.02M0.03M0.05M0.06M0.01M0.02M0.03M0.04M0.00M0.01M0.01M0.01M0.11M0.11M0.11M0.01M0.01M
Gains from Investment Securities (Quarter)
0.02M0.41M0.44M0.02M1.36M5.00M0.02M0.40M1.68M3.74M0.02M0.50M1.83M1.53M0.32M0.05M0.69M-21.27M-3.30M
Non-cash Items (Quarter)
15.79M30.29M2.83M1.37M1.60M0.09M2.06M0.07M2.77M12.50M3.05M0.17M0.10M0.28M4.53M0.04M6.45M0.03M0.73M
Cash from Operations (Quarter)
-20.14M-20.72M-17.16M-20.84M-16.76M-19.91M-18.22M-25.25M-16.57M-13.37M-13.43M-10.50M19.95M-13.67M-14.16M28.98M-14.48M-17.50M-2.00M-22.34M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.37M0.38M0.39M0.44M0.45M0.47M0.49M0.50M0.49M0.46M0.45M0.44M0.45M0.38M0.38M0.50M0.38M0.34M0.32M0.34M
Change in Working Capital
Change in Receivables (Quarter)
30.00M-12.50M-5.00M
Change in Account Payables (Quarter)
4.76M-3.55M-1.19M-0.82M-0.40M0.24M1.46M-1.36M-0.81M0.54M-0.44M-0.30M0.51M-0.28M1.60M-0.59M2.11M-1.80M0.43M-1.68M
Change in Accured Expenses (Quarter)
-1.53M-0.30M0.84M-1.43M4.63M-3.09M1.47M-3.87M0.66M2.28M1.10M-2.50M1.25M-0.21M-0.09M-6.38M1.16M3.31M0.93M-1.54M
Other Working Capital Changes (Quarter)
1.43M2.20M-4.16M-0.34M-0.05M-0.90M0.94M-0.21M-0.86M0.39M-0.24M39.12M-2.36M-2.26M-1.72M-0.96M39.09M-40.71M30.46M1.21M
Investing Activities
Capital Expenditures (Quarter)
0.36M0.11M-0.18M0.25M0.77M-0.65M-0.35M0.17M0.32M0.02M0.01M0.01M0.29M0.13M0.10M0.56M
Cash from Investing Activities (Quarter)
-0.44M-0.11M-0.38M-0.25M-0.77M-0.33M-0.51M-0.17M-0.32M-0.01M-0.01M-0.02M-0.40M-0.10M-0.56M
Financing Activities
Other financing activities (Quarter)
1.55M
Cash from Financing Activities (Quarter)
-0.35M0.30M115.83M-0.01M-0.02M-0.02M-0.02M-1.69M-0.99M-2.24M-1.63M0.95M20.04M-0.00M8.20M4.83M47.36M-0.28M35.87M35.71M
Additional items
Change in Cash (Quarter)
-20.92M-20.53M98.29M-21.09M-17.55M-20.26M-18.75M-27.11M-17.88M-15.61M-15.06M-9.55M39.98M-13.68M-5.96M33.79M32.48M-17.78M33.77M12.81M
Free Cash Flow (Quarter)
-20.50M-20.83M-16.98M-21.09M-17.53M-19.25M-17.87M-25.42M-16.89M-13.37M-13.43M-10.52M19.95M-13.68M-14.16M28.69M-14.61M-17.50M-2.09M-22.90M
Net Cash Flow (Quarter)
-20.92M-20.53M98.29M-21.09M-17.55M-20.26M-18.75M-27.11M-17.88M-15.61M-15.06M-9.55M40.00M-13.68M-5.96M33.79M32.48M-17.78M33.77M12.81M